Lymphoproliferative lung disorders: Clinicopathological aspects

European Respiratory Review

Volumn 22, Issue 130, 2013, Pages 427-436

  Poletti, Venerino ^a   Ravaglia, Claudia ^a   Tomassetti, Sara ^a   Gurioli, Carlo ^a   Casoni, Gianluca ^a   Asioli, Silvia ^a   Dubini, Alessandra ^a   Piciucchi, Sara ^a   Chilosi, Marco ^b  

^a MORGAGNI PIERANTONI HOSPITAL   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

METHOTREXATE; NATALIZUMAB;

ARTICLE; BRONCHUS BIOPSY; CANCER CLASSIFICATION; CANCER GRADING; CANCER SURVIVAL; CLASSICAL HODGKIN LYMPHOMA; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; ENDOSCOPIC BIOPSY; FOLLICULAR LYMPHOMA; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LABORATORY SYNDROME; LARGE CELL LYMPHOMA; LUNG CANCER; LUNG DISEASE; LUNG LAVAGE; LUNG LESION; LYMPHOPROLIFERATIVE DISEASE; MALIGNANT PARENCHYMAL LYMPHOPROLIFERATIVE LESION; MARGINAL ZONE LYMPHOMA; MOLECULAR BIOLOGY; MYCOSIS FUNGOIDES; NK T CELL LYMPHOMA; NONHODGKIN LYMPHOMA; POSTTRANSPLANTATION LYMPHOPROLIFERATIVE DISORDER; PRIMARY PULMONARY LYMPHOMA; PRIMARY TUMOR; PROGNOSIS; PSEUDOLYMPHOMA; RARE DISEASE; REACTIVE PULMONARY LYMPHOID DISEASE; RETICULOSARCOMA; SYNDROME; THORACOSCOPY; THORAX RADIOGRAPHY; TRANSBRONCHIAL BIOPSY; WORLD HEALTH ORGANIZATION; CANCER STAGING; CLASSIFICATION; LUNG DISEASES; LUNG NEOPLASMS; LYMPHOPROLIFERATIVE DISORDERS; ORGAN TRANSPLANTATION; PREDICTIVE VALUE; RISK FACTOR; TREATMENT OUTCOME;

HUMANS; LUNG DISEASES; LUNG NEOPLASMS; LYMPHOPROLIFERATIVE DISORDERS; NEOPLASM STAGING; ORGAN TRANSPLANTATION; PREDICTIVE VALUE OF TESTS; RISK FACTORS; TREATMENT OUTCOME;

EID: 84888771717     PISSN: 09059180     EISSN: 16000617     Source Type: Journal    
DOI: 10.1183/09059180.00004313     Document Type: Article

References (59)

1. Saltzstein S. Pulmonary malignant lymphomas and pseudolymphomas. Classification, therapy and prognosis. Cancer 1963; 16: 928-955.
2. Papaionnaou AN, Watson W. Primary lymphoma of the lung. An appraisal of its natural history and a comparison with other localized lymphomas. J Thorac Cardiovascular Surg 1965; 49: 373-387.
3. Addis BJ, Hyiek E, Isaacson PG. Primary pulmonary lymphoma. A re-appraisal of its hystogenesis and its relationship to pseudo lymphoma and lymphoid interstitial peumonia. Histopathology 1988; 13: 1-17.
4. Swerdlow SH, Campo E, Harris NL, et al., eds. WHO Classification of Tumours of Hematopoietic and Lymphoid tissues. Lyon, IARC Press, 2008.
5. Nicholson AG, Poletti V, Semenzato G. Lymphoproliferative lung disease. In: Gibson J, Geddes D, Costabel U, et al., eds. Respiratory Medicine. 3rd Edn. London, Harcourt Health Sciences, 2003; pp. 1694-1707.
6. Ahmed S, Kussick SJ, Siddiqui AK, et al. Bronchial-associated lymphoid tissue lymphoma: a clinical study of a rare disease. Eur J Cancer 2004; 40: 1320-1326.
7. Guinee DG, Franks TJ, Gerbino AJ, et al. Pulmonary nodular lymphoid hyperplasia (pulmonary pseudolymphoma): the significance of increased numbers of IgG4-positive plasma cells. Am J Surg Pathol 2013; 37: 699-709.
8. Castleman B, Iverson L, Menendez VP. Localized mediastinal lymphnode hyperplasia resembling thymoma. Cancer 1956; 9: 822-830.
9. Herrada J, Cabanillas F, Rice L, et al. The clinical behavior of localized and multicentric Castleman disease. Ann Intern Med 1998; 128: 657-662.
10. Oksenhendler E, Boulanger E, Galicier L, et al. High incidence of Kaposi sarcoma-associated herpes virus-related non-Hodgkin lymphoma in patients with HIV infection and multicentric Castleman disease. Blood 2002; 99: 2331-2336.
11. Izumi M, Mochizuki M, Kuroda M, et al. Angiomyoid proliferative lesion: an unusual stroma-rich variant of Castleman's disease of hyaline-vascular type. Virchows Arch 2002; 44: 400-405.
12. Chadburn A, Abdul-Nabi AM, Teruya BS, et al. Lymphoid proliferations associated with human immunodeficiency virus infection. Arch Pathol Lab Med 2013; 137: 360-370.
13. Dossier A, Meignin V, Fieschi C, et al. Human herpes virus 8-related Castleman disease in the absence of HIV infection. Clin Infect Dis 2013; 56: 833-842.
14. De Boer JP, Hiddink RF, Raderer M, et al. Dissemination patterns in non-gastric MALT lymphoma. Haematologica 2008; 93: 201-206.
15. Zinzani PL, Martelli M, Poletti V, et al. Practice guidelines for the management of extranodal non-Hodgkin lymphomas of adult non-immunodeficient patients. Part I: primary lung and mediastinal lymphomas. Haematologica 2008; 93: 1364-1371.
16. Thieblemont C, Berger F, Dumontet C, et al. Mucosa-associated lymphoid tissue lymphoma is a disseminated disease in one third of 158 patients analyzed. Blood 2000; 95: 802-806.
17. Li G, Hansmann ML, Zwingers T, et al. Primary lymphomas of the lung: morphological, immunohistochemical and clinical features. Histopathology 1990; 16: 519-531.
18. Kurtin PJ, Myers JL, Adlakha H, et al. Pathologic and clinical features of primary pulmonary extranodal marginal zone B-cell lymphoma of MALT type. Am Surg Pathol 2001; 25: 997-1008.
19. Remstein ED, Dogan A, Einerson RR, et al. The incidence and anatomic site specificity of chromosomal translocations in primary extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) in North America. Am J Surg Pathol 2006; 30: 1546-1553.
20. Kido T, Yatera K, Noguchi S, et al. Detection of MALT1 gene rearrangements in BAL fluid cells for the diagnosis of pulmonary mucosa-associated lymphoid tissue lymphoma. Chest 2012; 141: 176-182.
21. Bertoni F, Zucca E. Delving deeper into MALT lymphoma biology. J Clin Invest 2006; 116: 22-26.
22. Isaacson PG, Du MQ. MALT lymphoma: from morphology to molecules. Nat Rev Cancer 2004; 4: 644-653.
23. Colby TV. Current histological diagnosis of lymphomatoid granulomatosis. Mod Pathol 2012; 25: Suppl. 1, S39-S42.
24. Hoshida Y, Tomita Y, Zhiming D, et al. Lymphoproliferative disorders in autoimmune diseases in Japan. Analysis of clinicopathological features and Epstein-Barr virus infection. Int J Cancer 2004; 108: 443-449.
25. Ochi N, Yamane H, Yamagishi T, et al. Methotrexate-induced lymphoproliferative disease: Epstein-Barr virusassociated lymphomatoid granulomatosis. J Clin Oncol 2013; 31: e348-350.
26. Dunleavy K, Roschewski M, Wilson WH. Lymphomatoid granulomatosis and other Epstein-Barr virus associated lymphoprolifetive processes. Curr Hematol Malig Rep 2012; 7: 208-215.
27. Katzenstein AL, Doxtader E, Narendra S. Lymphomatoid granulomatosis: insights gained over 4 decades. Am J Surg Pathol 2010; 34: e35-e48.
28. Yu H, Chen G, Zhang R, et al. Primary intravascular large B-cell lymphoma of the lung: a report on one case and review. Diagn Pathol 2012; 7: 70-74.
29. Ponzoni M, Ferreri AJ, Campo E, et al. Definition, diagnosis, and management of intravascular large B-cell lymphoma: proposals and perspectives from an international consensus meeting. J Clin Oncol 2007; 25: 3168-3173.
30. Rodriguez J, Romaguerra JE, Manning J, et al. Nasal-type T/NK lymphomas: a clinicopathologic study of 13 cases. Leuk Lymphoma 2000; 39: 139-144.
31. Ren YL, Nong L, Zhang S, et al. Analysis of 142 Northern Chinese patients with peripheral T/NK-cell lymphomas: subtype distribution, clinicopathologic features, and prognosis. Am J Clin Pathol 2012; 138: 435-447.
32. Sverzellati N, Poletti V, Chilosi M, et al. The crazy-paving pattern in granulomatous mycosis fungoides: HRCTpathologic correlation. J Comput Assist Tomogr 2006; 30: 843-845.
33. Yousem SA, Weiss LM, Colby TV. Primary pulmonary Hodgkin's disease. Cancer 1986; 57: 1217-1224.
34. Radin AI Primary pulmonary Hodgkin's disease, Cancer 1990; 65: 550-563.
35. Cartier Y, Johkoh T, Honda O, et al. Primary pulmonary Hodgkin's disease: CT findings in three patients. Clin Radiol 1999; 54: 182-184.
36. William J, Variakojis D, Yeldandi A, et al. Lymphoproliferative neoplasms of the lung. A review. Arch Pathol Lab Med 2013; 137: 382-391.
37. Daniels CE, Myers JL, Utz JP, et al. Organizing pneumonia in patients with hematologic malignancies: a steroidresponsive lesion. Respir Med 2007; 101: 162-168.
38. Wang H, Wu D, Xiang H, et al. Pulmonary non-Hodgkin's lymphoma developed during long-term methotrexate therapy for rheumatoid arthritis. Rheumatol Int 2012; 32: 3639-3642.
39. Ebeo CT, Girish MR, Byrd RP, et al. Methotrexate-induced pulmonary lymphoma. Chest 2003; 123: 2150-2153.
40. Jois RN, Gaffney K, Cane P, et al. Methotrexate-associated lymphoproliferative disorder masquerading as interstitial lung disease. Histopathology 2007; 51: 709-712.
41. Borie R, Wislez M, Thabut G, et al. Clinical characteristics and prognostic factors of pulmonary MALT lymphoma. Eur Respir J 2009; 34: 1408-1416.
42. Bae YA, Lee KS, Han J, et al. Marginal zone B-cell lymphoma of bronchus-associated lymphoid tissue: imaging findings in 21 patients. Chest 2008; 133: 433-440.
43. Wislez M, Cadranel J, Antoine M, et al. Lymphoma of pulmonary mucosa-associated lymphoid tissue: CT scan findings and pathologic correlations. Eur Respir J 1999; 14: 423-429.
44. Watanabe Y, Koyama S, Miwa C, et al. Pulmonary mucosa-associated lymphoid tissue (MALT) lymphoma in Sjogren syndrome showing only the LIP pattern radiologically. Intern Med 2012; 51: 491-495.
45. Motta G, Conticello C, Amato G, et al. Pleuric presentation of extranodal marginal zone lymphoma of mucosaassociated lymphoid tissue: a case report and a review of the literature. Int J Hematol 2010; 92: 369-373.
46. Zhang WD, Guan YB, Li CX, et al. Pulmonary mucosa-associated lymphoid tissue lymphoma: computed tomography and 18F fluorodeoxyglucose-positron emission tomography/computed tomography imaging findings and follow-up. J Comput Assist Tomogr 2013; 35: 608-613.
47. Cordier J, Chailleux E, Lauque D, et al. Primary pulmonary lymphomas. A clinical study of 70 cases in nonimmunocompromised patients. Chest 1993; 103: 201-208.
48. Addis BJ. Pulmonary lymphoproliferative diseases. In: Hasleton P, Flieder DB, eds. Spencer's Pathology of the Lung. Vol. 2. Cambridge, Cambridge University Press, 2013; pp. 1316-1374.
49. Hare SS, Souza CA, Bain G, et al. The radiological spectrum of pulmonary lymphoproliferative disease. Br J Radiol 2012; 85: 848-864.
50. Lee JS, Tuder R, Lynch DA. Lymphomatoid granulomatosis: radiologic features and pathologic correlations. AJR Am J Roentgenol 2000; 175: 1335-1339.
51. Matsui S, Hebisawa A, Sakai F, et al. Immunoglobulin G4-related lung disease: clinicoradiological and pathological features. Respirology 2013; 18: 480-487.
52. Rossi G, Marchioni A, Guicciardi N, et al. A rare cause of fever and PET-positive nodules in the lungs. Clin Respir J 2009; 3: 118-120.
53. Kotake T, Kosugi S, Takimoto T, et al. Intravascular large-B cell lymphoma presenting pulmonary arterial hypertension as an initial manifestation. Intern Med 2010; 49: 51-54.
54. Souza CA, Quan K, Seely J, et al. Pulmonary intravascular lymphoma. J Thorac Imaging 2009; 24: 231-233.
55. Wagner T, Brechemier D, Dugert E, et al. Diffuse pulmonary uptake on FDG-PET with normal CT diagnosed as intravascular large B-cell lymphoma: a case report and a discussion on the causes of diffuse FDG uptake in the lungs. Cancer Imaging 2012; 12: 7-12.
56. Lee BH, Kim SY, Kim MY, et al. CT of nasal-type T/NK cell lymphoma in the lung. J Thorac Imaging 2006; 21: 37-39.
57. Poletti V, Romagna M, Gasponi A, et al. Bronchoalveolar lavage in the diagnosis of low-grade, MALT type, B-cell lymphoma in the lung. Monaldi Arch Chest Dis 1995; 50: 191-194.
58. Poletti V, Chilosi M, Olivieri D. Diagnostic invasive procedures in diffuse infiltrative lung diseases. Respiration 2004; 71: 107-119.
59. Zompi S, Couderc LJ, Cadranel J, et al. Clonality analysis of alveolar B lymphocytes contributes to the diagnostic strategy in clinical suspicion of pulmonary lymphoma. Blood 2004; 103: 3208-3215.